Hailed as the first Chinese company to launch a homegrown antibody drug conjugate (ADC), RemeGen has recently been battling a ...

CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2 ...

Swedish fintech Klarna took the next step in its highly anticipated U.S. IPO on Friday when it made its F-1 public. Here are ...

Belrise Industries aims to raise Rs 2,150 crore, while Paramesu Biotech plans to mop up Rs 600 crore through the public issue. Sebi had received their preliminary IPO documents in November and issued ...

This was the fourth biotech IPO of 2025, and the company raised around $219 million in its IPO, intended to advance its cystic fibrosis treatments. That is a market dominated Vertex ...